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Qiang Guo1*, Daguo Zhao1, Fenglin Dong1, Shenlan Liu1, Youguo Chen1, Jun Jin1, Dustin R Fraidenburg2
and Jian-an Huang1Pregnant women are susceptible to severe pneumonia
and acute respiratory distress syndrome (ARDS) from
influenza, which has been associated with increased fetal
loss [1]. There is very little experience for the manage-
ment of pregnant women with severe pneumonia and
ARDS from avian influenza A (H7N9) virus, especially
when complicated by intrauterine fetal death (IUFD).
A 28-year-old pregnant woman was admitted to the
hospital due to dyspnea, dry cough, and fever. The pa-
tient was at 26 weeks gestation. Infection with influenza
A (H7N9) virus was confirmed from a tracheal aspirate
sample using polymerase chain reaction assays. The
fetus was monitored daily to check the heart rate and on
admission the fetal heart rate was 140 beats/minute. The
patient’s initial blood pressure was 70/45 mmHg, which
was unresponsive to volume resuscitation. Norepineph-
rine was administrated to rescue septic shock and was
required until day 11. On day 2, the beating of the fetal
heart stopped as a result of severe, refractory hypoxemia
(arterial oxygen pressure <50 mmHg, 24 hours). Echo-
cardiography showed severe right ventricular dysfunc-
tion and severe left ventricular systolic dysfunction with
decreased ejection fraction (26%). The renal function
was slightly reduced with an elevated serum creatinine
level (225 μmol/l).
Despite the administration of oseltamivir, the patient’s
condition progressed quickly. Thoracic imaging show-
ing diffuse bilateral infiltrates along with evidence of
impaired gas exchange led to the diagnosis of ARDS.
Difficulties in oxygenation and a deteriorating medical* Correspondence: ggqq1018@hotmail.com
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unless otherwise stated.condition resulted in incremental positive end-expiratory
pressure titrations to a maximal value of 18 cmH2O and
plateau pressure titrations to 40 cmH2O. During this
course, the right ventricular systolic pressure was elevated
to 52 mmHg on day 12.
Severe pneumonia, septic shock, acute renal failure,
acute heart failure, pulmonary hypertension, and ARDS
complicated with IUFD posed a complex dilemma. On
day 13, application of 200 μg misoprostol in the poster-
ior fornix of the vagina was used to induce delivery with
an induction-to-termination interval of 11.5 hours. No
retained placenta or membranes were detected. Oxyto-
cin augmentation (intramuscular injection, 10 mg) was
given to prevent bleeding. In this complicated situation,
misoprostol appears to be a safe, effective, and practical
method for termination of IUFD [2]. Moreover, the heart
function, refractory hypoxemia, pulmonary hypertension,
and immunological function improved quickly on the
day after the successful delivery (Table 1). Despite inten-
sive medical therapies, catheter-related bloodstream in-
fection and ARDS was complicated by severe pulmonary
hypertension and the patient expired on hospital day 29.
Delivery of the fetus following IUFD using misoprostol
in multiple organ failure patients was associated with
improved immunological function, oxygenation, and
heart function in this patient. We cannot help but con-
sider that this may have provided more benefit early in
the patient’s hospital course. Further studies may help
identify the appropriate delivery time point and safety of
this agent in IUFD women complicated with multiple
organ failure.td. This is an Open Access article distributed under the terms of the Creative
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Table 1 Blood oxygenation, heart function, myocardial enzyme spectrum, and blood cell count data before and after
the fetal death delivery in a 28-year-old woman infected with influenza A (H7N9) virus
Day prior to fetal death delivery Day after fetal death delivery
Oxygenation and respiratory data
PaO2/FiO2 150 187
Positive end-expiratory pressure (mmHg) 10 9
Plateau pressure (mmHg) 28 25
Lung compliance (ml/cmH2O) 43.4 61.5
Basic circulation data
Heart rate (beats/minute) 135 114
Mean arterial blood pressure (mmHg) 105 86
Vasoactive agent None None
Echocardiographic data
Left ventricular ejection fraction (%) 33 68
Right ventricular systolic pressure (mmHg) 52 42
Left ventricular end-diastolic diameter (mm/m2) 41 43
Left ventricular end-systolic diameter (mm/m2) 35 29
Left atrial diameter (mm/m2) 36 27
Interventricular septal thickness (mm/m2) 9 9
Left ventricular posterior wall thickness (mm/m2) 8 7
Myocardial enzyme spectrum
Aspartate transaminase (u/l) 66 61
Creatine kinase (U/l) 377 122
Creatine kinase isomer-MB (u/l) 20 40
Lactate dehydrogenase (u/l) 448 411
Troponin (ng/ml) 0.15 0.12
Blood cell counts
White blood cells (×109/l) 26.7 27.4
Lymphocytes (×109/l) 0.7 1.8
CD4+ T lymphocytes (%) 9.0 42.4
CD8+ T lymphocytes (%) 14.5 37.3
CD4+/CD8+ 0.62 1.14
CD3−/CD19+ B lymphocytes (%) 7.7 2.3
CD3−CD56+ natural killer cells (%) 4.8 18.9
The ratio of arterial oxygen pressure (PaO2) to the fractional concentration of inspired oxygen (FiO2) (PaO2/FiO2), pulmonary dynamic compliance, heart rate, left
ventricular ejection fraction, right ventricular systolic pressure, left ventricular end-systolic diameter, creatine kinase isomer-MB, number of lymphocyte cells, CD4+
T-lymphocyte cell count, CD8+ T-lymphocyte cell count and CD3−CD56+ natural killer cell count were significantly improved after the fetal death delivery.
Guo et al. Critical Care 2014, 18:589 Page 2 of 3
http://ccforum.com/content/18/5/589Statement
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sent for the publication in the First Affiliated Hospital of
Soochow University, and this would be available for review
by the Editor-in-Chief.
Abbreviations
ARDS: Acute respiratory distress syndrome; IUFD: Intrauterine fetal death.
Acknowledgements
This work was supported by grants from the National Natural Science
Foundation of China (NSFC81300040), The Natural Science Foundation of
Jiangsu Province (BK20141184), and the China National Clinical Key Subject
and Application Foundation of Suzhou China (SYS201336).Author details
1Department of Medicine, Respiratory, Emergency and Critical Care Medicine,
The First Affiliated Hospital of Soochow University, 188 Shizhi st, Suzhou
215006, China. 2Department of Medicine, Division of Pulmonary, Critical Care,
Sleep and Allergy Medicine, University of Illinois at Chicago, Chicago, IL
60612, USA.References
1. Håberg SE, Trogstad L, Gunnes N, Wilcox AJ, Gjessing HK, Samuelsen SO,
Skrondal A, Cappelen I, Engeland A, Aavitsland P, Madsen S, Buajordet I,
Furu K, Nafstad P, Vollset SE, Feiring B, Nøkleby H, Magnus P, Stoltenberg C:
Guo et al. Critical Care 2014, 18:589 Page 3 of 3
http://ccforum.com/content/18/5/589Risk of fetal death after pandemic influenza virus infection or
vaccination. N Engl J Med 2013, 368:333–340.
2. Dodd JM, Crowther CA: Misoprostol for induction of labour to terminate
pregnancy in the second or third trimester for women with a fetal
anomaly or after intrauterine fetal death. Cochrane Database Syst Rev
2010, 4:CD004901.
doi:10.1186/s13054-014-0589-7
Cite this article as: Guo et al.: Delivery of fetus death with misoprostol
in a pregnant woman with H7N9 avian influenza A virus pneumonia
and ARDS. Critical Care 2014 18:589.
